Skip to content

Fatty15 supports Healthy Aging For All. Learn more.

Your Cart

Let us help you find something
Popular Searches

From the Navy to fatty15: A Doctor's Mission

The team behind the vision

Eric Venn-Watson,
MD, MBA

Co-Founder, Chief Operating Officer

Eric

is a practicing physician and entrepreneur. He served over 25 years as a Navy and Marine Corps physician, working with the special forces community to improve their health and fitness. Additionally, Eric founded multiple companies in the drug discovery, healthcare analytics, and medical device industries. He is passionate about developing medical technologies that improve the practice and delivery of healthcare on a global scale.

Did you know?

Eric attended the military medical school at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, received his general surgery and orthopedic surgery training at the Naval Medical Center San Diego, and completed his MBA at the UCSD, Rady School of Management.

Literature

Knute O. Buehler MD, Eric Venn-Watson BS, Darryl D. D'Lima MD, Clifford W. Colwell Jr MD: The Press-Fit Condylar total knee system: 8- to 10- year results with a posterior cruciate-retaining design. The Journal of Arthroplasty Volume 15, Issue 6, September 2000, Pages 698-701

Yashar AA, Venn-Watson E, Welsh T , Colwell CW Jr , Lotke P: Continuous passive motion with accelerated flexion after total knee arthroplasty. Clinical Orthopaedics and Related Research, 01 Dec 1997, (345):38-43.

Darryl D D'Lima, MD, Eric J Venn-Watson, MD, Prabhakar Tripuraneni, MD, and Clifford W Cowell, Jr, MD: Indomethacin Versus Radiation Therapy for Heterotopic Ossification After Hip Arthroplasty. Orthopedics, 2013;24(12):1139–1143.

Khiem D. Dao MD, Eric Venn-Watson BS, Alexander Y. Shin MD: Radial artery pseudoaneurysm complication from use of AO/ASIF volar distal radius plate: A case report. The Journal of Hand Surgery Volume 26, Issue 3, May 2001, Pages 448-453.

URQUHART, ANDREW G. M.D.; D'LIMA, DARRYL D. M.D.; VENN-WATSON, ERIC B.A.; COLWELL, CLIFFORD W. JR., M.D.; WALKER, RICHARD H. M.D., LA JOLLA, CALIFORNIA: Polyethylene Wear After Total Hip Arthroplasty: The Effect of a Modular Femoral Head with an Extended Flange-Reinforced Neck. The Journal of Bone & Joint Surgery 80(11):p 1641-7, November 1998.

Darryl D D'Lima, MD, Arnold A Yashar, MD, Eric J Venn-Watson, BS, Clifford W Colwell, Jr, MD, and Richard H Walker, MD: The Harris-Galante Porous Acetabular Component at Intermediate Follow-Up. Orthopedics, 2013;24(8):747–751.

Meet the rest of our team

The team behind the vision.

Society spent a generation avoiding fat, we've dedicated our lives to harnessing it.

The team behind the vision.

Society spent a generation avoiding fat, we've dedicated our lives to harnessing it.

Dr. Stephanie Venn-Watson in a light blue blouse and dark pants, standing against a white background.

Stephanie Venn-Watson, DVM, MPH

CO-CEO, CO-FOUNDER

Eric Venn-Watson in black polo shirt smiling.

Eric Venn-Watson, MD, MBA

CO-CEO, CO-FOUNDER

Smiling person in green shirt with dark hair, sitting against white background.

Kim Kamdar, PhD

BOARD CHAIR, CO-FOUNDER

Man in a blue shirt smiling confidently.

Nicholas Schork, PhD

Senior Scientist, Co-Founder

Smiling person in a light blue shirt on a white background.

Chris Doyle

Chief Financial Officer

A person in a light shirt smiling at the camera.

Dennis Bernstein, MBA

VP of Retention & Lifecycle Marketing

Ali Bernstein

Head of Consumer Experience & Engagement

Smiling woman in a light blazer against a neutral background.

Kate McMahon

Sr. Account Manager

Dr. Stephanie Venn-Watson in a light blue blouse and dark pants, standing against a white background.

Stephanie Venn-Watson, DVM, MPH

CO-CEO, CO-FOUNDER

Steph is a serial entrepreneur of for-profit and not-for-profit companies, a veterinary epidemiologist and public health scientist with over 40 patents and 70 peer-reviewed scientific publications, and previously served as an epidemiologist tracking diseases for the Centers for Disease Control and Prevention and World Health Organization.

Eric Venn-Watson in black polo shirt smiling.

Eric Venn-Watson, MD, MBA

CO-CEO, CO-FOUNDER

Eric is a practicing physician and entrepreneur. He served over 25 years as a Navy and Marine Corps physician, working with the special forces community to improve their health and fitness. Additionally, Eric founded multiple companies in the drug discovery, healthcare analytics, and medical device industries. He is passionate about developing medical technologies that improve the practice and delivery of healthcare on a global scale.

Smiling person in green shirt with dark hair, sitting against white background.

Kim Kamdar, PhD

BOARD CHAIR, CO-FOUNDER

Kim is a Managing Partner of Domain Associates, a life sciences venture capital firm, and has been involved in numerous cutting-edge therapeutic start-ups. She was also a research director at Novartis, where she led a team to uncover small molecules that modulated signaling pathway networks.

Man in a blue shirt smiling confidently.

Nicholas Schork, PhD

Senior Scientist, Co-Founder

Nicholas is a Distinguished Professor and Director of the Quantitative Medicine and Systems Biology Division at Translational Genomics Institute, an affiliate of The City of Hope. In addition, as a leader in the design and analysis of studies of longevity, Nicholas is Scientific Director for the National Institute of Health’s National Institute of Aging-sponsored Longevity Consortium.

Smiling person in a light blue shirt on a white background.

Chris Doyle

Chief Financial Officer

Chris is a finance leader focused on driving scale and profitability for high-growth businesses. Throughout his career, Chris has worked with both small and large companies to develop growth strategies, navigate operational hurdles, execute M&A transactions, and raise capital. He is passionate about developing data-driven insights to support long-term, sustainable business expansion. Chris began his career in investment banking at J.P. Morgan and Moelis, and he has held finance roles at Mars Wrigley, KIND and Diggs.

A person in a light shirt smiling at the camera.

Dennis Bernstein, MBA

VP of Retention & Lifecycle Marketing

Dennis is a marketing and brand builder, with an entrepreneurial mindset.  He has 20+ years of experience leading the development of innovative brands and launching successful consumer products into the marketplace, working at some of the most rapidly evolving Omni-channel and DTC companies, including Procter & Gamble and Dollar Shave Club. Dennis developed and led such projects as the Thank you Mom campaign for the London Olympics and global launches for the Crest/Oral B and Gillette brands.

Ali Bernstein

Head of Consumer Experience & Engagement

Ali is an expert when it comes to marketing and community building, with the number one priority of always putting the customer first. Ali's mission is to make customers’ feel like friends and part of the fatty15 family, helping people with any requests. With over 23+ years of marketing experience on both the agency and client side of the business building communities, at companies like Empower MediaMarketing, Ali enjoys bringing her personable nature to the fatty15 family.

Smiling woman in a light blazer against a neutral background.

Kate McMahon

Sr. Account Manager

Kate is a highly motivated professional experienced in non-profit fundraising, event and project management. With her leadership, organizational skills, effective communication, and optimistic attitude, she is an invaluable asset as our project manager. She excels in maintaining a holistic perspective while also paying meticulous attention to detail. Kate proactively seeks opportunities to improve and enhance processes for the benefit of the entire team.

Living abroad as a military family has honed her change management abilities and broadened her global perspective, fueling her desire to work for companies that make a positive impact on people's lives. She finds immense satisfaction in her role at Seraphina Therapeutics, where she actively contributes to their mission of advancing global health through the transformative fatty acid C15:0.